Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes

References

• Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775–85.
   PubMed Web of Science ®Google Scholar
• Hoffmann B, Schmidt-Traub H, Perrot A, Osterziel KJ, Gessner R. First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum Mutat 2001; 17:524.
   PubMedGoogle Scholar
• Marian A J, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 2001; 33: 655–70.
   Google Scholar
• Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 2002; 105:446–51.
   PubMed Web of Science ®Google Scholar
• Seidman CE, Seidman JG. Molecular genetic studies of familial hypertrophic cardiomyopathy. Basic Res Cardiol 1998;93:13–6.
   Google Scholar
• Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 1999;262:411–7.
   PubMed Web of Science ®Google Scholar
• Sorajja P, Elliott PM, McKenna WJ. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications. Europace 2000;2:4–14.
   Google Scholar
• de la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J Med Genet 1993;30: 857–65.
   PubMed Web of Science ®Google Scholar
• Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999;8:1913–23.
   Google Scholar
• Piippo K, Swan H, Pasternack M, Chapman H, Paavonen K, Viitasalo M, et al. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol 2001;37:562–8.
   PubMed Web of Science ®Google Scholar
• Watkins H, Thierfelder L, Anan R, Jarcho J, Matsumori A, McKenna W, et al. Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardio-myopathy. Am J Hum Genet 1993;53:1180–5.
   PubMed Web of Science ®Google Scholar
• Moolman-Smook JC, De Lange WJ, Bruwer EC, Brink PA, Corfield VA. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. Am J Hum Genet 1999;65:1308–20.
   Google Scholar
• Richard P, Charron P, Leclercq C, Ledeuil C, Carrier L, Dubourg 0, et al. Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000; 32: 1575–83.
   Google Scholar
• Enjuto M, Francino A, Navarro-Lopez F, Viles D, Pare JC, Ballesta AM. Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in beta-myosin heavy chain gene. J Mol Cell Cardiol 2000;32: 2307–13.
   Google Scholar
• Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995;11:438–40.
   PubMedGoogle Scholar
• Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998;338:1248–57.
   PubMed Web of Science ®Google Scholar
• Erdmann J, Raible J, Maki-Abadi J, Hummel M, Hammann J, Wollnik B, et al. Spectrum of clinical phenotypes and gene variants in cardiac myosin- binding protein C mutation carriers with hypertrophic cardiomyopathy. J Am Coll Cardiol 2001;38:322–30.
   Google Scholar
• Anan R, Shono H, Kisanuki A, Arima S, Nakao S, Tanaka H. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation 1998;98:391–7.
   PubMedGoogle Scholar
• Jääskeläinen P, Soranta M, Miettinen R, Saarinen L, Pihlajamäki J, Silvennoinen K, et al. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. J Am Coll Cardiol 1998;32: 1709–16.
   Google Scholar
• Jääskeläinen P, Kuusisto J, Miettinen R, Kärkkäinen P, Kärkkäinen S, Heikkinen S, et al. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland. J Mol Med 2002;80:412–22.
   Google Scholar
• Jääskeläinen P, Miettinen R, Silvennoinen K, Vauhkonen I, Laakso M, Kuusisto J. The cardiac troponin I gene is not associated with hypertrophic cardiomyopathy in patients from eastern Finland. J Mol Cell Cardiol 1999;31:2031–6.
   Google Scholar
• Kärkkäinen S, Peuhkurinen K, Jääskeläinen P, Miettinen R, Kärkkäinen P, Kuusisto J, et al. No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy. Am Heart J 2002;143:11–4.
   Google Scholar
• McKenna WJ, Spirito P, Desnos M, Dubourg 0, Komajda M. Experience from clinical genetics in hypertrophic cardiomyo-pathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997;77: 130–2.
   Google Scholar
• Anan R, Greve G, Thierfelder L, Watkins H, McKenna WJ, Solomon S, et al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994;93:280–5.
   PubMed Web of Science ®Google Scholar
• Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701–12.
   PubMed Web of Science ®Google Scholar
• Havndrup 0, Bundgaard H, Andersen PS, Larsen LA, Vuust J, Mogensen J, et al. Sarcomere gene mutations in 49 Danish families with familial hypertrophic cardiomyopathy (Ab-stract). Eur Heart J 2000;21: 13.
   Google Scholar
• Richard P, Charron P, Carrier L, Ledeuil C, Dubourg 0, Desnos M, et al. Distribution of disease genes in 102 geno-typed families with hypertrophic cardiomypathy (Abstract). Eur Heart J 2001;22: 635.
   Google Scholar
• Regitz-Zagrosek V, Erdmann J, Tanis N, Senyuva M, Werner U, Raible J, et al. Mutation spectrum in six disease genes in a large cohort of index patients with hypertrophic cardiomyo-pathy (Abstract). Circulation 2001;104 (supplement):11–521.
   Google Scholar
• Kimura A, Ito-Satoh M, Hayashi T, Takahashi M, Arimura T. Molecular etiology of idiopathic cardiomyopathy in Asian populations. J Cardiol 2001;37:139–46.
   Google Scholar
• Moolman-Smook JC, De Lange J, Brink A, Corfield A. Hypertrophic cardiomyopathy repealing tenets in South Africa. Cardiovasc J S Afr 2000;11:202–9.
   Google Scholar
• Mörner S, Richard P, Kazzam E, Hellman U, Hainque B, Söchwartz K, et al. Indentification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. J Mol Cell Cardiol 2003;35:841–9.
   Google Scholar
• Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardio-myopathy. N Engl J Med 1995;332:1058–64.
   Google Scholar
• Charron P, Dubourg 0, Desnos M, Bennaceur M, Carrier L, Camproux AC, et al. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 1998;97:2230–6.
   Google Scholar
• Coviello DA, Maron BJ, Spirito P, Watkins H, Vosberg HP, Thierfelder L, et al. Clinical features of hypertrophic cardio-myopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol 1997;29:635–40.
   PubMed Web of Science ®Google Scholar
• Blair E, Redwood C, de Jesus Oliveira M, Moolman-Smook JC, Brink P, Corfield VA, et al. Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy. Circ Res 2002;90:263–9.
   Google Scholar
• Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995;26:1529–36.
   Google Scholar
• Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999;281:650–5.
   PubMed Web of Science ®Google Scholar
• Farza H, Townsend PJ, Carrier L, Barton PJ, Mesnard L, Bährend E, et al. Genomic organisation, alternative splicing and polymorphisms of the human cardiac troponin gene. J Mol Cell Cardiol 1998;30:1247–53.
   Google Scholar
• Andersen PS, Havndrup 0, Bungaard H, Moolmand-Smook JC, Larsen LA, Mogensen J, et al. Myosin light chain mutations in familial hypertrophic cardiomyopathy: pheno-typic presentation and frequency in Danish and South African populations. J Med Genet 2001;38:E43.
   Google Scholar